Doxycycline Hyclate, Doxycycline HCL EP / BP

Hua	Doxycycline Hyclate
CAS	2058-46-0
Ingoa Matū:	4S (4aR, 5S, 5aR, 6R, 12aS)] - 4- (dimethylamino) -1,4,4a, 5,5a, 6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy- 6-methyl-1,11deoxonaphthacene-2-carboxamide monohydrochloride, whakauru ki te waipiro waipiro (2: 1 ）
Tātai rāpoi	C 22H 24N 2O 8· HCL · 1 / 2C 2H 5OH · 1 / 2H 2O
Taumaha Molecular	24390-14-5
Whakapaa	Kaweake i te takai tika
Rau Rauemi Haumaru Rauemi	Wātea i runga i te tono
Nga korero	roopu paturopi tetracycline

Ko te Doxycyline hydrochloride
Ko te Doxycycline hyclate he takawaenga tetracycline waihanga me te mahi antimicrobial rite.
 
Drug Indication 
1)Treatment of periodontal disease in dogs
 
2)Pigs: clinical signs with porcine respiratory disease. Chickens: to reduce mortality, morbidity, and clinical signs and to reduce lesions due to Pasteurellosis. Also in respiratory infections caused by Ornithobacterium rhinotracheale.
 
3)Treatment of infections of the respiratory tract and alimentary tract caused by micro-organisms susceptible to doxycycline.
 
4)Chickens: to reduce mortality, morbidity, and clinical signs and to reduce lesions due to Pasteurellosis caused by Pasteurella multocida or to reduce morbidity and lesions in respiratory infections caused by Ornithobacterium rhinotracheale (ORT)
 
5)Treatment of systemic amyloidosis caused by beta-2 microglobulin
 
6)Treatment of familial amyloid polyneuropathy